HIGHLIGHTS
- who: JoseĢ E. Meca-Lallana from the University of Turku, Finland have published the research work: Consensus on early detection of disease progression in patients with multiple sclerosis, in the Journal: (JOURNAL)
- what: The aim of this consensus is to identify early disease progression to help clinicians in detecting early signs of progression and make the most appropriate and timely therapeutic decisions in their practice.
- future: Experts also agreed that evidence of potential biomarkers such as sNfL levels meningeal ectopic lymphoid follicles and OCT measurements is promising and that these biomarkers together will . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.